NDC Compounded Drug 70092-147-03 Lidocaine Hydrochloride; Potassium Chloride

Injection Intravenous

Table of Contents

    1. Compounded Product Information
    2. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 70092-147
NDC Package Code 70092-147-03
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 70092014703
Package Description 100 mL in 1 BAG
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Kcl 10 Meq Lido 10 Mg Add 100 Ml Ns Bag
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Kcl 10 Meq Lido 10 Mg Add 100 Ml Ns Bag
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Lidocaine Hydrochloride; Potassium Chloride
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Route Name Intravenous - Administration within or into a vein or veins.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 70092
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Quva Pharma, Inc.
Substance Name Lidocaine Hydrochloride; Potassium Chloride
Active Ingredients Information 1000 mg/100 mL; 1000 meq/100 mL
Reporting Period 2022-2

Frequently Asked Questions

What is the NDC number assigned to Kcl 10 Meq Lido 10 Mg Add 100 Ml Ns Bag?

Kcl 10 Meq Lido 10 Mg Add 100 Ml Ns Bag was assigned by its manufacturer with NDC product code 70092-147. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Kcl 10 Meq Lido 10 Mg Add 100 Ml Ns Bag?

The NDC package code 70092-147-03 was assigned to a 100 mL in 1 BAG of lidocaine hydrochloride; potassium chloride administered intravenous via injection.

Who manufactures this product?

Kcl 10 Meq Lido 10 Mg Add 100 Ml Ns Bag is manufactured by an outsourced facility and labeled by Quva Pharma, Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.